Results 81 to 90 of about 9,100 (154)

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. [PDF]

Pak J Med Sci
Zuberi BF, Ali FS, Rasheed T, Bader N.
europepmc   +1 more source

Comparative effectiveness of antiviral therapies in chronic hepatitis B and C management. [PDF]

Bioinformation
Tiwari A, Tagore PK, Kumhar SD, Bardiya A.   +3 more
europepmc   +1 more source

Entecavir provides favorable virological control but minimal metabolic benefit in patients with Chronic Hepatitis B and MAFLD. [PDF]

Am J Transl Res
Wang B, Mo X, Wu X, Huang Y, Deng K, Liang Y, Lu Z, Wei H, Liang J, Huang Z.   +9 more
europepmc   +1 more source

Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. [PDF]

World J Hepatol
Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF.   +7 more
europepmc   +1 more source

Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. [PDF]

Mediterr J Hematol Infect Dis
Silva N, Duarte G, Medina S, Amarante GD, de Souza CA, Pagnano K.   +5 more
europepmc   +1 more source

Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. [PDF]

J Clin Transl Hepatol
Liu L, Xu Q, Lin S, Wei Z, Huang G.
europepmc   +1 more source

Monitoring Adherence and Renal Safety of Nucleos(t)ide Analogs for Patients With Chronic Hepatitis B. [PDF]

Clin Transl Gastroenterol
Hsu CC, Chen ZE, Chao FH, Chou CY, Chang YL, Chou YC, Hou MC, Wu JC, Su CW.   +8 more
europepmc   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B. [PDF]

JHEP Rep
Holmberg M, Niehrs A, Dalgard O, Berhe N, Desalegn H, Aleman S, Weis N, Stenstad T, Heggelund L, Samuelsen E, Karlsen LN, Lindahl K, Kleppa E, Winckelmann AA, Brugger-Synnes P, Simonsen HE, Svendsen J, Björkström NK, Reikvam DH, Johannessen A.   +19 more
europepmc   +1 more source

High Intrahepatic cccDNA in Resolved HBV Infection: Insights From Living Donor Liver Transplantation With Anti-HBc-Positive Grafts. [PDF]

J Gastroenterol Hepatol
Bae SK, Akamatsu N, Ichida A, Nishioka Y, Inagaki Y, Miyake N, Takamoto T, Kawaguchi Y, Tamura S, Arita J, Kaneko J, Otsuka M, Tanaka Y, Yotsuyanagi H, Moriya K, Hasegawa K.   +15 more
europepmc   +1 more source